Alumni Endowed Professor of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine RNA viruses use a ...

The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug can reduce the levels ...

PHILADELPHIA ­— Ten patients enrolled in the experimental drug trial, and they were the sickest of the sick. All had a genetic disorder that cranks up levels of LDL cholesterol in the blood. Known as ...

Cholesterol has a bad reputation, and statins are often seen as the only solution. But one doctor has said that many people can lower their cholesterol without medication.

Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...

Patients with severe hypercholesterolemia who are unresponsive to a number of lipid-lowering therapies, including a PCSK9 inhibitor and high-dose statin, can have a significant reduction in ...

A once-a-day tablet called enlicitide is reshaping expectations for cholesterol care, cutting low density lipoprotein, or ...

High levels of low-density lipoprotein (LDL) cholesterol can cause artery blockages and diseases like heart attacks and strokes. Further, it raises the risk of cardiovascular disease (CVD). Thickened ...

In today’s Health Alert, a promising new type of pill dramatically lowered artery-clogging cholesterol in a study of patients ...